Medtronic Offers Thin Body, Left-Heart Lead for CRT Devices


May 6, 2009

Medtronic's Attain Ability left‐heart lead (Model 4196) is designed for use with cardiac resynchronization therapy (CRT) devices for heart failure patients. Attain Ability reportedly has the thinnest lead body of any left‐heart lead currently available, providing physicians with a tool to deliver therapy directly to hard‐to‐reach areas of the heart.

Attain Ability incorporates insulation material developed by NASA Langley Research Center that was previously evaluated for space applications, high‐performance engines and harsh environments. The compact, flexible design afforded by the NASA insulation material makes this the thinnest left‐heart lead body on the market, the company said. Medtronic said its design allows physicians to choose between different sites in order to deliver optimal therapy. Additionally, Attain Ability can be delivered by an inner catheter, the Attain Select II. This feature helps physicians place the lead directly in difficult‐to‐reach areas of the heart.

In addition to the U.S., the Attain Ability lead is available in Europe, Japan, Canada, and Australia. The lead is compatible with the Attain family of exclusive delivery tools including the Attain Select II, the Attain Hybrid Guide Wires and Attain Command, the newest family of left‐heart lead delivery catheters now available in the U.S. and Canada.

The lead was FDA approved in May 2009.